ArticleJournal of chemical information and modeling2026
A Relative Binding Free Energy Framework for Structurally Dissimilar Molecules.
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Five-Decade Journey of Small Cell Lung Cancer.Cancer communications (London, England) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Relative binding free energy (RBFE) calculations, widely used to predict the potencies of congeneric small molecules binding to a protein receptor, can greatly increase the efficiency of the hit-to-lead and lead optimization stages of the drug discovery process. Traditional RBFE methods, however, cannot be easily applied to small molecules lacking a common core or binding mode, precluding their use in a challenging but crucial component of many drug discovery campaigns. In principle, an absolute binding free energy (ABFE) method can be applied to such molecules, but ABFE often suffers from high computational cost and poor statistical convergence due to the large amount of additional sampling required when compared to RBFE. Here, we introduce core-hopping binding free energy (CBFE) calculations, a computationally efficient framework for the accurate determination of relative binding free energies between small molecules with different cores, leveraging several recently developed techniques such as Alchemical Enhanced Sampling (ACES) with optimized transformation pathways and flexible λ-spacing, as well as λ-dependent Boresch restraints. We benchmark the performance of CBFE across 4 protein systems consisting of 56 small molecules, and find that the results are consistent with RBFE for a congeneric series of ligands and offer considerable improvement in computational cost and precision relative to ABFE results for a series of small molecules with diverse cores and binding modes. All CBFE-related developments are fully implemented in the GPU-accelerated AMBER free energy module (pmemd.cuda) and are available as part of the latest official AMBER release.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.